| Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. |
| Highlights: |
| View the latest trials here. |
| A summary of the highlighted trial is now available in French, Mandarin, Russian, and Spanish. Support equal access to nephrology research: Become an ISN Member! |
Kidney International® A randomized controlled trial evaluated the effect of pravastatin on... read more
After two decades of research, the causes of chronic kidney disease of undetermined... read more
Kidney International® Establishing a core outcome measure for life participation in children... read more
A recent Kidney International® editorial showcases the ISN-Global Kidney Health Atlas (ISN-GKHA) Interactive Map, an open-access tool... read more
At WCN’26, the high-impact trials (HIT) and late-breaking clinical trials (LBCT) sessions will show you what matters most for patient... read more
Across the ISN’s research groups and committees, this year has been... read more
Kidney disease research is entering a pivotal moment. Kidney International® published... read more
Kidney International® Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and... read more
Kidney International® The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis People... read more
ISN-ACT Global Trials Focus (GTF) editorial team member Michele Provenzano summarizes... read more
